Drug Type Prophylactic vaccine, Conjugated vaccine |
Synonyms Haemophilus b conjugate vaccine(Chengdu Olymvax Biopharmaceuticals) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (18 May 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Haemophilus Infections | CN | 18 May 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Phase 2 | CN | 28 Sep 2013 | |
Cellulitis | Phase 2 | CN | 28 Sep 2013 | |
Epiglottitis | Phase 2 | CN | 28 Sep 2013 | |
Meningitis | Phase 2 | CN | 28 Sep 2013 | |
Pneumonia | Phase 2 | CN | 28 Sep 2013 |
Phase 3 | 1,992 | (Vaccine(Chengdu Olymvax Biopharmaceuticals Inc.)) | kbuxjfcurr(nshvcdbuki) = kdnlmmjbww pzehkpksue (vemlllarah, tmblnwjujv - zwiyqffgbb) View more | - | 21 Aug 2017 | ||
(Vaccine (Walvax Biotechnology Co., LTD.)) | kbuxjfcurr(nshvcdbuki) = zfeqpkbskx pzehkpksue (vemlllarah, ecfewycury - asfkvuszsk) View more |